Mechanisms and functions of vitamin D

Nutrition Reviews

Volumn 56, Issue 2 II, 1998, Pages

  DeLuca, Hector F ^a   Zierold, Claudia ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; RETINOID X RECEPTOR; TRANSCRIPTION FACTOR; VITAMIN D; VITAMIN D RECEPTOR;

CONFERENCE PAPER; GENETIC TRANSCRIPTION; GRAFT REJECTION; MULTIPLE SCLEROSIS; PROMOTER REGION; RHEUMATOID ARTHRITIS;

EID: 0031955392     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-4887.1998.tb01686.x     Document Type: Conference Paper

References (58)

1. DeLuca HF. Vitamin D: the vitamin and the hormone. Fed Proc 1974;33:2211-9
2. DeLuca HF, Schnoes HK. Vitamin D: recent advances. Ann Rev Biochem 1983;52:411-39
3. 3 from bone, liver, and blood serum. J Lipid Res 1966;7:739-44
4. Morii H, Lund J, Neville PF, DeLuca HF. Biological activity of a vitamin D metabolite. Arch Biochem Biophys 1967;120:508-12
5. DeLuca HF. Vitamin D: 1993. Nutr Today 1993;28:6-11
6. DeLuca HF. The vitamin D story: a collaborative effort of basic science and clinical medicine. FASEB J 1988;2:224-36
7. DeLuca HF. The control of calcium and phosphorus metabolism by the vitamin D endocrine system. In: Levander OA, Cheng L, eds. Micronutrient interactions: vitamins, minerals, and hazardous element. New York, NY: New York Academy of Sciences, 1980;355:1-17
8. DeLuca HF. New concepts of vitamin D functions. In: Sauberlich HE, Machlin KJ, eds. Beyond deficiency. New views on the function and health effects of vitamins. New York, NY: New York Academy of Sciences, 1992;669:59-69
9. 3 identified by thaw-mount autoradiography. In: Cohn DV, Talmage RV, Matthews JL, eds. Hormonal control of calcium metabolism. Amsterdam, The Netherlands: Exerpta Medica, 1981:22-229
10. 3 in intestinal tract, stomach, kidney, skin, pituitary and parathyroid. Science 1979;206:1188-90
11. Fraser D, Kooh SW, Kind HP, et al. Pathogenesis of hereditary vitamin D dependent rickets: an inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1α,25-dihydroxyvitamin D. New Engl J Med 1973;289:817-22
12. Boyle IT, Miravet L, Gray RW, et al. The response of intestinal calcium transport to 25-hydroxy and 1,25-dihydroxy vitamin D in nephrectomized rats. Endocrinology 1972;90:605-8
13. 3 active on bone in anephric rats. Science 1971; 176:1146-7
14. 3. Endocr Rev 1985;6:491-511
15. 3. Chem Pharm Bull 1984;32:3525-31
16. 2 analogs which differ markedly in biological activity in vivo. J Biol Chem 1994;269:24014-9
17. Pike JW, Haussler MR. Purification of chicken intestinal receptor for 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 1979;76:5485-9
18. 3 from chicken intestine. Biochemistry 1983;22:2586-94
19. 3: interaction with distinct receptor domains. Biochemistry 1986;25:4523-34
20. 3. J Biol Chem 1983;258:1289-96
21. Baker AR, McDonnell DP, Hughes M, et al. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA 1988;85:3294-8
22. 3 receptor cDNA. Proc Natl Acad Sci USA 1988;85:1005-9
23. 3 receptor. Proc Natl Acad Sci USA 1988;85:9499-502
24. McDonnell DP, Pike JW, O'Malley BW. The vitamin D receptor: a primitive steroid receptor related to thyroid hormone receptor. J Steroid Biochem 1988;30:41-7
25. Lu Z, Hanson K, DeLuca HF. Cloning and origin of the two forms of chicken vitamin D receptor. Arch Biochem Biophys 1997;339:99-106
26. Jehan F, DeLuca HF. Cloning and characterization of the mouse vitamin D receptor promoter. Proc Natl Acad Sci USA 1997;94:10138-43
27. 3 receptors: structure and function in transcription. Annu Rev Nutr 1991;11:189-216
28. vom Baur E, Zechel C, Heery D, et al. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J 1996;15:110-24
29. Ross TK, Darwish HM, DeLuca HF. Molecular biology of vitamin D action. In: Litwack G, ed. Vitamins and hormones. San Diego, CA: Academic Press, 1994;49:281-326
30. Zierold C, Darwish HM, DeLuca HF. Two vitamin D response elements function in the rat 1,25-dihydroxyvitamin D 24-hydroxylase promoter. J Biol Chem 1995;270:1675-8
31. Chen K-S, DeLuca HF. Cloning of the human 1α,25-dihydroxyvitamin D-3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements. Biochim Biophys Acta 1995;1263:1-9
32. 3 receptors. Cell 1991;65:1255-66
33. Munder M, Herzberg IM, Zierold C, et al. Identification of the porcine intestinal accessory factor that enables DNA sequence recognition by vitamin D receptor. Proc Natl Acad Sci USA 1995;92:2795-9
34. 3 signaling. Nature 1991;355:446-9
35. 3 receptor in the absence of the retinoid X receptor. Mol Endocrinol 1994;8:265-73
36. Lemon BL, Freedman, LP. Selective effects of ligands on vitamin D3 receptor-and retinoid X receptor-mediated gene activation in vivo. Mol Cell Biol 1996;16:1006-16
37. Kurokawa R, DiRenzo J, Boehm M, et al Regulation of retinoid signaling by receptor polarity and allosteric control of ligand binding. Nature 1994;371:528-31
38. Masuyama H, Jefcoat S Jr, MacDonald PN. The N-terminal domain of transcription factor MB is required for direct interaction with the vitamin D receptor and participates in vitamin D-mediated transcription. Mol Endocrinol 1997;11:218-28
39. Blanco JCG, Wang I-M, Tsai SY. Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription. Proc Natl Acad Sci USA 1995;92:1535-9
40. Zierold C, Strugnell SA, DeLuca HF. Transcription factor IIB is required for complex formation of the vitamin D receptor with its response element. J Bone Min Res 1995;10(Suppl 1):5395
41. 3 dependency of VDR-RXR-VDRE complex formation. Arch Biochem Biophys 1997;341:75-80
42. 3. Endocrinology 1984;115: 1476-83
43. 3: potential relation of a plasmalemmal receptor to the acute enhancement of intestinal calcium transport in chick. J Nutr 1995;125:1695S-8S
44. Brooks MH, Bell NH, Love L, et al. Vitamin D-dependent rickets Type II. Resistance of target organs to 1,25-dihydroxyvitamin D. New Engl J Med 1978;298:996-9
45. Rosen JF, Fleischman AR, Finberg L, et al. Rickets with alopecia: an inborn error of vitamin D metabolism. J Pediatr 1979;94:729-35
46. Wiese RJ, Goto H, Prahl JM, et al. Vitamin D-dependency rickets type II: truncated vitamin D receptor in three kindreds. Mol Cell Endocrinol 1993;90:197-201
47. Hughes M, Malloy P, Kieback D, et al. Human vitamin D receptor mutations: identification of molecular defects in hypocalcemic vitamin D resistant rickets. Adv Exp Med Biol 1989;255:491-503
48. 3 resistant rickets in seven related families. J Clin Invest 1990;86:2071-9
49. Yoshizawa T, Handa Y, Uematsu Y, et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nature Genetics 1997;16:391-6
50. 3. Proc Natl Acad Sci USA 1981;78:4990-4
51. Tanaka H, Abe E, Miyaura C, et al. 1α,25-Dihydroxychole-calciferol and a human myeloid leukaemia cell line (HL-60). The presence of a cytosol receptor and induction of differentiation. Biochem J 1982;204:713-9
52. 3 receptor. Cancer Res 1984;44:2103-9
53. 3 receptors in cancer. Lancet 1980;i:1188
54. 3 and the skin: a unique application for the treatment of psoriasis. Proc Soc Exp Biol Med 1989;191:246-57
55. 3 and the immune system. Proc Soc Exp Biol Med 1989;191:238-45
56. 2 suppress immunoglobulin production and thymic lymphocyte proliferation in vivo. Biochim Biophys Acta 1993;1158:269-86
57. Yang S, Smith C, Prahl JM, et al. Vitamin D deficiency suppress cell-mediated immunity in vivo. Arch Biochem Biophys 1993;303:98-106
58. 3 reversibly blocks the progression of relapsing encephalomyelitis. Proc Natl Acad Sci USA 1996;93:7861-4